 |
 |
 |
 |
 |
 |
 |
| Aglaia is proud to work together with scientists and management in the following companies: | ||
| • | ISA Pharmaceuticals B.V. Immune System Activation |  |
| • | ORCA Therapeutics B.V. Oncolytic Replicating Competent Agents |  |
| • | Merus B.V. Oligoclonal antibodies |  |
| • | InteRNA Technologies B.V. Intelligent RNA technologies and applications • InteRNA Genomics B.V. The Genome Informatics Specialist |   |
| • | Somantix B.V. Targeting tumor angiogenesis |  |
| Aglaia has realized the following exits: | ||
| • | Syntarga B.V. Linking activity to specificity |  |